BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xourgia E, Tzouganatou EM, Papazafeiropoulou A, Melidonis A. Anti-inflammatory properties of antidiabetic agents. World J Meta-Anal 2019; 7(4): 129-141 [DOI: 10.13105/wjma.v7.i4.129]
URL: https://www.wjgnet.com/2308-3840/full/v7/i4/129.htm
Number Citing Articles
1
Nami Lee, Yu Jung Heo, Sung-E Choi, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Yup Kang, Kwan Woo Lee, Hae Jin Kim, Theresa Hautz. Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling PathwaysJournal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/9944880
2
Alina Kuryłowicz, Krzysztof Koźniewski. Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 DiabetesMolecules 2020; 25(9): 2224 doi: 10.3390/molecules25092224
3
Mohsen Mohammadgholi, Seyed Jalal Hosseinimehr. Crosstalk between Oxidative Stress and Inflammation Induced by Ionizing Radiation in Healthy and Cancerous CellsCurrent Medicinal Chemistry 2024; 31(19): 2751 doi: 10.2174/0929867330666230407104208
4
Rodrigo Damián García, Joana Antonela Asensio, Diahann Jeanette Perdicaro, María de los Ángeles Peral. The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular DiseasesCurrent Vascular Pharmacology 2022; 20(3): 244 doi: 10.2174/1570161120666220201160038
5
Milena Cojic, Aleksandra Klisic, Amina Sahmanovic, Nemanja Petrovic, Gordana Kocic. Cluster analysis of patient characteristics, treatment modalities, renal impairments, and inflammatory markers in diabetes mellitusScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56451-1